Form 8-K - Current report:
SEC Accession No. 0001104659-25-002872
Filing Date
2025-01-13
Accepted
2025-01-13 08:09:13
Documents
54
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm253046d1_8k.htm   iXBRL 8-K 29698
2 EXHIBIT 99.1 tm253046d1_ex99-1.htm EX-99.1 18473
3 EXHIBIT 99.2 tm253046d1_ex99-2.htm EX-99.2 55113
7 GRAPHIC tm253046d1_ex99-1img001.jpg GRAPHIC 6908
8 GRAPHIC tm253046d1_ex99-2img001.jpg GRAPHIC 135868
9 GRAPHIC tm253046d1_ex99-2img002.jpg GRAPHIC 410681
10 GRAPHIC tm253046d1_ex99-2img003.jpg GRAPHIC 245906
11 GRAPHIC tm253046d1_ex99-2img004.jpg GRAPHIC 123087
12 GRAPHIC tm253046d1_ex99-2img005.jpg GRAPHIC 130261
13 GRAPHIC tm253046d1_ex99-2img006.jpg GRAPHIC 135679
14 GRAPHIC tm253046d1_ex99-2img007.jpg GRAPHIC 193885
15 GRAPHIC tm253046d1_ex99-2img008.jpg GRAPHIC 137602
16 GRAPHIC tm253046d1_ex99-2img009.jpg GRAPHIC 193508
17 GRAPHIC tm253046d1_ex99-2img010.jpg GRAPHIC 135690
18 GRAPHIC tm253046d1_ex99-2img011.jpg GRAPHIC 171659
19 GRAPHIC tm253046d1_ex99-2img012.jpg GRAPHIC 141093
20 GRAPHIC tm253046d1_ex99-2img013.jpg GRAPHIC 213752
21 GRAPHIC tm253046d1_ex99-2img014.jpg GRAPHIC 135501
22 GRAPHIC tm253046d1_ex99-2img015.jpg GRAPHIC 163665
23 GRAPHIC tm253046d1_ex99-2img016.jpg GRAPHIC 164026
24 GRAPHIC tm253046d1_ex99-2img017.jpg GRAPHIC 159329
25 GRAPHIC tm253046d1_ex99-2img018.jpg GRAPHIC 212633
26 GRAPHIC tm253046d1_ex99-2img019.jpg GRAPHIC 242195
27 GRAPHIC tm253046d1_ex99-2img020.jpg GRAPHIC 185193
28 GRAPHIC tm253046d1_ex99-2img021.jpg GRAPHIC 151539
29 GRAPHIC tm253046d1_ex99-2img022.jpg GRAPHIC 122803
30 GRAPHIC tm253046d1_ex99-2img023.jpg GRAPHIC 129882
31 GRAPHIC tm253046d1_ex99-2img024.jpg GRAPHIC 253862
32 GRAPHIC tm253046d1_ex99-2img025.jpg GRAPHIC 173299
33 GRAPHIC tm253046d1_ex99-2img026.jpg GRAPHIC 197625
34 GRAPHIC tm253046d1_ex99-2img027.jpg GRAPHIC 132484
35 GRAPHIC tm253046d1_ex99-2img028.jpg GRAPHIC 126134
36 GRAPHIC tm253046d1_ex99-2img029.jpg GRAPHIC 212690
37 GRAPHIC tm253046d1_ex99-2img030.jpg GRAPHIC 174502
38 GRAPHIC tm253046d1_ex99-2img031.jpg GRAPHIC 151618
39 GRAPHIC tm253046d1_ex99-2img032.jpg GRAPHIC 129332
40 GRAPHIC tm253046d1_ex99-2img033.jpg GRAPHIC 164994
41 GRAPHIC tm253046d1_ex99-2img034.jpg GRAPHIC 143437
42 GRAPHIC tm253046d1_ex99-2img035.jpg GRAPHIC 120406
43 GRAPHIC tm253046d1_ex99-2img036.jpg GRAPHIC 149181
44 GRAPHIC tm253046d1_ex99-2img037.jpg GRAPHIC 125546
45 GRAPHIC tm253046d1_ex99-2img038.jpg GRAPHIC 78363
  Complete submission text file 0001104659-25-002872.txt   9090545

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atxs-20250113.xsd EX-101.SCH 3018
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20250113_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20250113_pre.xml EX-101.PRE 22361
56 EXTRACTED XBRL INSTANCE DOCUMENT tm253046d1_8k_htm.xml XML 3691
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 25524920
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)